Estropipate

Trade Name:

Ogen

Pfizer

Status:

discontinued

Presentation:

Tablets: 0.625 mg, 1.25 mg, 2.50 mg

Comments:

Pfizer is globally discontinuing Ogen (estropipate) tablets due to supply and manufacturing issues. There are currently no other manufacturers of estropipate in Canada.

Posted	Updated
2010-01-30 12:00	2010-01-30 12:01

Back to:

Drug Product Listings

Browse by keywords:

All material found on the BC Drug and Poison Information Centre (DPIC) website is provided for informational purposes only. It is not meant to replace the expert advice of a healthcare professional such as a physician, pharmacist, nurse or qualified poison specialist. Use of this site is governed and restricted by specific terms of use. Please review the terms and conditions prior to using the DPIC website. In the event of a poisoning emergency, call your local poison control centre immediately. Portions of this web site are intended for healthcare professionals. Interpretation and application of information may require more detailed explanation than contained herein, particularly regarding any clinical information that is found in or linked to this site. Patients are advised to consult their health care provider regarding diagnosis and treatment, and for assistance in interpreting these materials and applying them in individual cases.

British Columbia Drug and Poison Information Centre (BC DPIC)

Poison Information

Drug Information

Publications

Estropipate

E-mail Subscriptions